Literature DB >> 6587384

Characterization of a cDNA coding for human factor X.

S P Leytus, D W Chung, W Kisiel, K Kurachi, E W Davie.   

Abstract

A lambda gt11 cDNA library containing DNA inserts prepared from human liver mRNA has been screened with an antibody to human factor X, a plasma protein participating in the middle phase of the blood coagulation cascade. Ten positive clones were isolated from 2 X 10(6) phage and plaque purified. The cDNA in the phage containing the largest insert has been sequenced and shown to code for human factor X. This cDNA insert contained 1137 base pairs coding for a portion of the light chain of the molecule, a connecting region, the heavy chain, a stop codon, a short 3' noncoding region, and a poly(A) tail. The sequence of A-T-T-A-A-A, which functions as a potential recognition site for polyadenylylation or processing, was present in the 3' end of the coding sequence and preceded the stop codon of TGA by 1 base pair and the poly(A) tail by 14 base pairs. The amino acid sequence deduced from the cDNA indicated that factor X is synthesized as a single-chain polypeptide containing the light and heavy chains connected by an Arg-Lys-Arg tripeptide. The single-chain molecule is then converted to the light and heavy chains by cleavage of two (or more) internal peptide bonds. In plasma, these two chains are linked together by a disulfide bond. The DNA sequence coding for the active site of human factor X showed a high degree of identity with prothrombin and factor IX, two other vitamin K-dependent serine proteases that participate in blood coagulation. These data along with the protein sequence data previously published for the light chain of human factor X establish the complete amino acid sequence for the mature protein present in plasma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6587384      PMCID: PMC345286          DOI: 10.1073/pnas.81.12.3699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Bovine factor X1 (Stuart factor): amino-acid sequence of heavey chain.

Authors:  K Titani; K Fujikawa; D L Enfield; L H Ericsson; K A Walsh; H Neurath
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

2.  Bovine factor X1 (Stuart factor). Primary structure of the light chain.

Authors:  D L Enfield; L H Ericsson; K A Walsh; H Neurath; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

3.  Identification of gamma-carboxyglutamic acid residues in bovine factors IX and X, and in a new vitamin K-dependent protein.

Authors:  D Bucher; E Nebelin; J Thomsen; J Stenflo
Journal:  FEBS Lett       Date:  1976-10-01       Impact factor: 4.124

4.  Chromatography of human prothrombin complex or dextran sulphate agarose.

Authors:  D S Pepper; C Prowse
Journal:  Thromb Res       Date:  1977-11       Impact factor: 3.944

5.  Activation of human factor X (Stuart factor) by a protease from Russell's viper venom.

Authors:  R G Di Scipio; M A Hermodson; E W Davie
Journal:  Biochemistry       Date:  1977-11-29       Impact factor: 3.162

6.  The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways.

Authors:  K Fujikawa; M H Coan; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1974-12-17       Impact factor: 3.162

7.  Bovine factor X 1 (Stuart factor). Mechanism of activation by protein from Russell's viper venom.

Authors:  K Fujikawa; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

8.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

9.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

10.  erythro-beta-Hydroxyaspartic acid in bovine factor IX and factor X.

Authors:  T Sugo; P Fernlund; J Stenflo
Journal:  FEBS Lett       Date:  1984-01-02       Impact factor: 4.124

View more
  23 in total

1.  Production of a self-activating CBM-factor X fusion protein in a stable transformed Sf9 insect cell line using high cell density perfusion culture.

Authors:  Volker M Gorenflo; Tom A Pfeifer; Gary Lesnicki; Emily M Kwan; Thomas A Grigliatti; Douglas G Kilburn; James M Piret
Journal:  Cytotechnology       Date:  2004-03       Impact factor: 2.058

2.  Molecular genetic analysis of factor X deficiency: gene deletion and germline mosaicism.

Authors:  K Wieland; D S Millar; C B Grundy; R S Mibashan; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

3.  Human complement component C3: cDNA coding sequence and derived primary structure.

Authors:  M H de Bruijn; G H Fey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13, and alpha 1-acid glycoprotein to chromosome 9.

Authors:  M Rocchi; L Roncuzzi; R Santamaria; N Archidiacono; L Dente; G Romeo
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

5.  Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones.

Authors:  C F Catterall; A Lyons; R B Sim; A J Day; T J Harris
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

6.  Intrinsic versus extrinsic coagulation. Kinetic considerations.

Authors:  B J Warn-Cramer; S P Bajaj
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

7.  Genes for mast-cell serine protease and their molecular evolution.

Authors:  R Huang; L Hellman
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  The length of the linker between the epidermal growth factor-like domains in factor VIIa is critical for a productive interaction with tissue factor.

Authors:  Egon Persson; Jesper J Madsen; Ole H Olsen
Journal:  Protein Sci       Date:  2014-10-14       Impact factor: 6.725

9.  Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.

Authors:  H H Watzke; A Wallmark; N Hamaguchi; P Giardina; D W Stafford; K A High
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Characterization of a cDNA coding for human protein C.

Authors:  D Foster; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.